ICU Medical, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference Print
Monday, 06 January 2014 10:10

SAN CLEMENTE, Calif.--ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will be presenting at the 32nd


  ICU Medical's presentation will take place on Thursday, January 16 at 10:30 AM Pacific Time. 

The presentation will be webcast live and can be accessed by going to the Company's website at, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.

A copy of the slides to be presented may be found by going to the Company's website at, clicking on the Investors tab, clicking on Presentations and clicking on the January 2014 Investor Presentation.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections, protecting healthcare workers from exposure to infectious diseases or hazardous. The Company's complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needlefree IV connectors, catheters and

cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at

CONTACT: ICU Medical, Inc.          Scott Lamb, Chief Financial Officer          (949) 366-2183                    ICR, LLC          John F. Mills, Senior Managing Director          (310) 954-1105

BiomedReports is not paid or compensated by newswires to disseminate or report news and

Error. Page cannot be displayed. Please contact your service provider for more details. (30)

developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and
investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!